Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.6.6 appears on the page, updating from v3.6.5. This reflects a software or interface update to the study page rather than a modification to the study details.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a minor platform update to the page.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor software update to the page. This update does not modify study content or patient-facing information.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a new version of the page content.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, signaling a new page version rather than a content change.SummaryDifference0.1%

- Check98 days agoChange DetectedThe recruitment status was updated to 'No longer looking for participants', and the header text was standardized from 'Intervention / Treatment' to 'Intervention/Treatment' with a new revision label 'Revision: v3.6.0'. Additionally, new help sections were added: 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.